Trademark Search in Canada

ACUREX

View On IC.GC.CA

REGISTERED

on 11 Oct 2024

Last Applicant/ Owned by

AcureX Biosciences Corporation

930 Brittan AvenueSan Carolos CA 94070

Serial Number

2130945 filed on 14^th Jun 2021

Registration Number

TMA1262625 registered on 11^th Oct 2024

Registration expiry Date

14^th Jun 2031

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

M5H3Y2

ACUREX

Trademark usage description

pharmaceutical preparations for neurodegenerative diseases, disorders, and conditions; pharmaceutical preparations for the treatment of neurological d Read More

Classification Information

Class [005]
Pharmaceutical preparations for neurodegenerative diseases, disorders, and conditions; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, Parkinson's, epilepsy, cerebral palsy, Alzheimer's, multiple sclerosis, muscular dystrophy, central nervous system diseases and disorders, mitochondrial diseases and disorders, and metabolic diseases and disorders; pharmaceutical preparations for the prevention and treatment of Parkinson's disease, Alzheimer's, ALS, huntington's, and diseases of aging; therapeutic agents for removal of damaged mitochondrial cells for medical purposes; diagnostic biomarker regents, assays and medical diagnostic tests consisting of diagnostic agents, all for the detection of Parkinson's disease, Alzheimer's, ALS, Huntington's, diseases of aging, and other mitochondrial diseases.

Classification kind code

Class [042]
Pharmaceutical research and development services in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's disease, Alzheimer's, ALS, Huntington's, and diseases of aging; providing medical and scientific research and information in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's disease, Alzheimer's, ALS, Huntington's, and diseases of aging; diagnostic research and development services for drug discovery in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's, Alzheimer's, ALS, Huntington's, and diseases of aging.

Classification kind code

Mark Details

Serial Number

2130945

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 30^th Dec 2022	Agent Changed
Submitted for opposition 22 on 12^th Dec 2022	Search Recorded
Submitted for opposition 20 on 12^th Dec 2022	Examiner's First Report
Submitted for opposition 223 on 12^th Dec 2022	Total Provisional Refusal
Submitted for opposition 256 on 4^th Jul 2022	Notification of Possible Opposition Sent
Submitted for opposition 257 on 2^th Sept 2021	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 1^st Sept 2021	Formalized
Submitted for opposition 1 on 1^st Sept 2021	Created
Submitted for opposition 30 on 14^th Jun 2021	Filed
Submitted for opposition 228 on 14^th Jun 2021	International Registration